共 43 条
[1]
Sancho JM(2006)Compassionate use of intrathecal depot liposomal cytarabine as treatment of central nervous system involvement in acute leukemia: report of 6 cases Haematologica 91 ECR02-3116
[2]
Ribera JM(1999)Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis J Clin Oncol 17 3110-2193
[3]
Romero MJ(1993)Extended CSF cytarabine exposure following intrathecal administration of DTC 101 J Clin Oncol 11 2186-1851
[4]
Martin-Reina V(2007)Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphoma Leuk Lymphoma 48 1849-199
[5]
Giraldo P(1986)The risks of central nervous system relapse and leukencephalopathy in patients receiving marrow transplants for acute leukaemia Blood 67 195-917
[6]
Ruiz E(1989)Central nervous system relapses after bone marrow Transplantation for acute leukaemia in remission Cancer 64 1796-3218
[7]
Glantz MJ(1995)Pharmacokinetics of intralumbar DTC-101 for the treatment of leptomeningeal metastases Arch Neurol 52 912-undefined
[8]
LaFollette S(2007)Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia Blood 109 3214-undefined
[9]
Jaeckle KA(undefined)undefined undefined undefined undefined-undefined
[10]
Shapiro W(undefined)undefined undefined undefined undefined-undefined